1. Home
  2. SPRY vs WEN Comparison

SPRY vs WEN Comparison

Compare SPRY & WEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRY
  • WEN
  • Stock Information
  • Founded
  • SPRY 2015
  • WEN 1969
  • Country
  • SPRY United States
  • WEN United States
  • Employees
  • SPRY N/A
  • WEN N/A
  • Industry
  • SPRY Biotechnology: Pharmaceutical Preparations
  • WEN Restaurants
  • Sector
  • SPRY Health Care
  • WEN Consumer Discretionary
  • Exchange
  • SPRY Nasdaq
  • WEN Nasdaq
  • Market Cap
  • SPRY 1.8B
  • WEN 2.1B
  • IPO Year
  • SPRY N/A
  • WEN N/A
  • Fundamental
  • Price
  • SPRY $11.62
  • WEN $10.56
  • Analyst Decision
  • SPRY Strong Buy
  • WEN Hold
  • Analyst Count
  • SPRY 4
  • WEN 17
  • Target Price
  • SPRY $28.75
  • WEN $14.03
  • AVG Volume (30 Days)
  • SPRY 2.3M
  • WEN 6.9M
  • Earning Date
  • SPRY 08-13-2025
  • WEN 08-08-2025
  • Dividend Yield
  • SPRY N/A
  • WEN 5.28%
  • EPS Growth
  • SPRY N/A
  • WEN N/A
  • EPS
  • SPRY N/A
  • WEN 0.96
  • Revenue
  • SPRY $112,339,000.00
  • WEN $2,225,413,000.00
  • Revenue This Year
  • SPRY N/A
  • WEN N/A
  • Revenue Next Year
  • SPRY $182.40
  • WEN $3.18
  • P/E Ratio
  • SPRY N/A
  • WEN $11.05
  • Revenue Growth
  • SPRY 22367.80
  • WEN 1.31
  • 52 Week Low
  • SPRY $10.00
  • WEN $9.74
  • 52 Week High
  • SPRY $18.90
  • WEN $20.60
  • Technical
  • Relative Strength Index (RSI)
  • SPRY 25.12
  • WEN 50.02
  • Support Level
  • SPRY $13.32
  • WEN $10.19
  • Resistance Level
  • SPRY $14.00
  • WEN $10.72
  • Average True Range (ATR)
  • SPRY 1.00
  • WEN 0.29
  • MACD
  • SPRY -0.30
  • WEN 0.05
  • Stochastic Oscillator
  • SPRY 9.88
  • WEN 59.21

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

About WEN Wendy's Company (The)

The Wendy's Company is the second-largest burger quick-service restaurant, or QSR, chain in the United States by systemwide sales, with $12.6 billion in 2024, narrowly edging Burger King ($11.5 billion) and clocking in well behind wide-moat McDonald's ($51.1 billion). After divestitures of Tim Hortons (2006) and Arby's (2011), the firm manages just the burger banner, generating sales across a footprint that spanned more than 7,200 total stores in 30 countries as of year-end 2024. Wendy's generates revenue from the sale of hamburgers, chicken sandwiches, salads, and fries throughout its company-owned footprint, through franchise royalty and marketing fund payments remitted by its franchisees, which account for roughly 94% of stores, and through franchise flipping and advisory fees.

Share on Social Networks: